Corcept Therapeutics (CORT)
(Delayed Data from NSDQ)
$23.88 USD
+0.56 (2.40%)
Updated May 1, 2024 04:00 PM ET
After-Market: $26.90 +3.02 (12.65%) 7:58 PM ET
1-Strong Buy of 5 1
D Value D Growth C Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/01/2024
Time: AMC |
3/2024 | $0.21 | 0.00% |
Earnings Summary
For their last quarter, Corcept Therapeutics (CORT) reported earnings of $0.25 per share, beating the Zacks Consensus Estimate of $0.21 per share. This reflects a positive earnings surprise of 19.05%. Look out for CORT's next earnings release expected on August 07, 2024. For the next earning release, we expect the company to report earnings of $0.24 per share, reflecting a year-over-year increase of 50%.
Earnings History
Price & Consensus
Zacks News for CORT
Corcept (CORT) Upgraded to Strong Buy: Here's What You Should Know
CORT: What are Zacks experts saying now?
Zacks Private Portfolio Services